Mar 04, 2013 08:19 EST Kauppalehti, a leading economic newspaper of Finland, has published two articles about BioNavis. The first one is a review of the company development entitled “A Lesson to Technology Companies”, while the second article is an evaluation written by a senior venture capitalist Petri Niemi. Based on BioNavis' performance, the company is expected to grow to a 5-7 million euro business in a few years.
Dec 20, 2012 17:18 EST In 2012, BioNavis Ltd secured five times higher instrument order intake than in 2011. While many companies are forced to restructure their operations, BioNavis has hired several professionals with deep understanding of the technology and its applications in the UK, USA, China, Germany and Finland, effectively doubling the amount of personnel in the company.
May 02, 2012 17:40 EDT BioNavis Ltd. announces the winners of the International Multi-Parametric Surface Plasmon Resonance (MP-SPR) Contest. The winning proposals from New Zealand and from Poland are both based on assessing new types of active polymers. The applications of such smart polymers include solar, biosensors, smart implants, drug delivery, and toxicology for instance.
Jan 31, 2012 06:06 EST Traditional surface plasmon resonance (SPR) has been used in drug discovery for more than 20 years. Now, with BioNavis SPR Navi 200 and SPR Navi 220A instruments, SPR phenomena can be used also in biophysics, biomaterials, and biosensor development. Furthermore, SAMP-SPR by BioNavis and Episentec enhances the capabilities of the SPR technology increasing its sensitivity and specificity 100-fold!